A common misconception around retail engagement strategies is that engaging retail is only worthwhile if the goal is to grow ...

Pfizer’s Talzenna is now the first PARP inhibitor approved by the FDA to treat men with metastatic hormone-sensitive prostate ...

Pfizer’s Jeff Legos discusses how science, AI and patient insights are shaping cancer research and the next generation of ...

PORTAGE, Mich. — Roughly 150 people at Pfizer's Portage factory are now out of a job. Company officials confirmed the layoffs Tuesday, citing lower volumes at the site as a result of lower demand for ...

Pfizer and its CEO misled Florida residents about the safety and effectiveness of the company’s COVID-19 vaccine, according to a lawsuit from Florida’s attorney general. Pfizer deceived consumers ...

Add Yahoo as a preferred source to see more of our stories on Google. Pfizer CEO Albert Bourla looks on, on the day U.S. President Donald Trump (not pictured) announces a deal with Pfizer to sell ...

Oct 1 (Reuters) - Florida Attorney General James Uthmeier on Thursday filed a lawsuit against Pfizer (PFE.N), opens new tab and its CEO, Albert Bourla, ‌accusing the drugmaker of misleading consumers ...

Pfizer has made significant progress in addressing some of its challenges. However, the company still has a rocky road ahead. Launching newer medicines could help Pfizer overcome the obstacles ahead.

Pfizer has raised its dividend every year for over a decade, then something changed. Before you count on that 6% yield, find out what the payout's own behavior is quietly signaling about the company's ...

Pfizer shareholders are collecting a 6% yield while the stock bleeds value, and the CEO just made a bold promise about keeping that payout alive through what could be the company's toughest stretch in ...

It must have been a pretty good few months for Pfizer investors (PFE) as the stock surprisingly outperformed the S&P 500 (SPX) (SPY) during this period since I last updated PFE in May. In my previous ...

People who purchased Chantix during a six-year period could be eligible to receive money from a $44 million class action settlement over allegations that the smoking-cessation drug contained an ...